# Iteration 096 — Engineering Report

**Result**: Identical to baseline. OOS Sharpe +1.01, IS Sharpe +0.73. The Sharpe overflow fix had zero impact.

## Configuration

Identical to iter 093 (baseline) except: Sharpe overflow guard (|Sharpe|>100 → -10.0).

## Results

| Metric | Iter 096 | Baseline (093) | Difference |
|--------|----------|----------------|------------|
| IS Sharpe | +0.73 | +0.73 | 0.00 |
| IS WR | 42.8% | 42.8% | 0.0 pp |
| IS PF | 1.19 | 1.19 | 0.00 |
| IS MaxDD | 92.9% | 92.9% | 0.0% |
| IS Trades | 346 | 346 | 0 |
| OOS Sharpe | +1.01 | +1.01 | 0.00 |
| OOS WR | 42.1% | 42.1% | 0.0 pp |
| OOS Trades | 107 | 107 | 0 |

All metrics identical to baseline. The Sharpe overflow fix changed nothing because:
1. The degenerate trial (Sharpe=1e15) only occurred in one month (2023-01) for one seed (1001)
2. The ensemble averages across 5 seeds, diluting the effect of one bad seed
3. The final predictions were identical despite different trial selection in that one case

## Label Leakage Audit

- CV gap: 44 rows, verified on all folds
- No leakage detected

## Conclusion

The Sharpe overflow fix is a correctness improvement (prevents degenerate trial selection) but has zero measurable effect on the baseline's walk-forward results. It should be kept in the codebase for robustness.
